KEPTIDE Trademark

Trademark Overview

On Friday, June 5, 2020, a trademark application was filed for KEPTIDE with the United States Patent and Trademark Office. The USPTO has given the KEPTIDE trademark a serial number of 88951184. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 27, 2023. This trademark is owned by Sotira, LLC. The KEPTIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment and prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical preparations for SARS-CoV2 or COVID-19; Pharmaceutical preparations, namely, elixirs for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Chemical preparations for pharmaceutical or medical purposes, namely, for SARS-CoV2 or COVID-19; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Therapeutic pharmaceutical for the treatment of SARS-CoV2 or C...
keptide

General Information

Serial Number88951184
Word MarkKEPTIDE
Filing DateFriday, June 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment and prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical preparations for SARS-CoV2 or COVID-19; Pharmaceutical preparations, namely, elixirs for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Chemical preparations for pharmaceutical or medical purposes, namely, for SARS-CoV2 or COVID-19; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Therapeutic pharmaceutical for the treatment of SARS-CoV2 or COVID-19

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSotira, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPhoenix, AZ 85016
Party NameSotira, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPhoenix, AZ 85016

Trademark Events

Event DateEvent Description
Monday, November 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2023SOU EXTENSION 4 GRANTED
Thursday, April 27, 2023SOU EXTENSION 4 FILED
Thursday, June 8, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, June 7, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, June 7, 2023PETITION TO REVIVE-GRANTED
Wednesday, June 7, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, January 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 5, 2023SOU EXTENSION 3 GRANTED
Thursday, October 27, 2022SOU EXTENSION 3 FILED
Saturday, December 3, 2022NOTICE OF REVIVAL - E-MAILED
Friday, December 2, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, December 2, 2022PETITION TO REVIVE-GRANTED
Friday, December 2, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, November 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2022SOU EXTENSION 2 GRANTED
Wednesday, April 27, 2022SOU EXTENSION 2 FILED
Tuesday, July 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 2, 2022NOTICE OF REVIVAL - E-MAILED
Wednesday, June 1, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, June 1, 2022PETITION TO REVIVE-GRANTED
Wednesday, June 1, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 30, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 23, 2021SOU EXTENSION 1 GRANTED
Thursday, September 23, 2021SOU EXTENSION 1 FILED
Thursday, September 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 19, 2021ASSIGNED TO EXAMINER
Tuesday, June 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 9, 2020NEW APPLICATION ENTERED

Related Keywords

keptide pharmaceutical preparations sars treatment covid diseases disorders respiratory prevention namely